A detailed history of Wellington Management Group LLP transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 623,973 shares of NUVB stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
623,973
Previous 340,331 83.34%
Holding current value
$1.76 Million
Previous $993,000 44.51%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.3 - $3.83 $652,376 - $1.09 Million
283,642 Added 83.34%
623,973 $1.44 Million
Q2 2024

Aug 13, 2024

BUY
$2.58 - $3.69 $878,053 - $1.26 Million
340,331 New
340,331 $993,000
Q2 2021

Aug 16, 2021

SELL
$9.22 - $14.48 $7.45 Million - $11.7 Million
-808,325 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$9.0 - $14.57 $7.27 Million - $11.8 Million
808,325 New
808,325 $8.22 Million

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $613M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.